Skip to main content
SpringerLink
Log in

Organ Specific Issues of PTLD — Kidney

  • Chapter
Post-Transplant Lymphoproliferative Disorders

  • 856 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dharnidharka VR, Tejani AH, Ho PL, et al. Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk. Am J Transplant. 2002;2:993–8

    Article  PubMed  Google Scholar 

  2. Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant. 2004;4:222–30

    Article  PubMed  Google Scholar 

  3. Kasiske BL, Snyder JJ, Gilbertson DT, et al. Cancer after kidney transplantation in the United States. Am J Transplant. 2004;4:905–13

    Article  PubMed  Google Scholar 

  4. Caillard S, Dharnidharka V, Agodoa L, et al. Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation. 2005;80:1233–43

    Article  PubMed  CAS  Google Scholar 

  5. Caillard S, Lelong C, Pessione F, et al. Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French registry. Am J Transplant. 2006;6:2735–42

    Article  PubMed  CAS  Google Scholar 

  6. Shapiro R, Nalesnik M, McCauley J, et al. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation. 1999;68:1851–4

    Article  PubMed  CAS  Google Scholar 

  7. Dharnidharka VR, Sullivan EK, Stablein DM, et al. Risk factors for posttransplant lymphopro-liferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation. 2001;71:1065–8

    Article  PubMed  CAS  Google Scholar 

  8. McDonald RA, Smith JM, Ho M, et al. Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. Am J Transplant. 2008;8:984–9

    Article  PubMed  CAS  Google Scholar 

  9. Opelz G, Naujokat C, Daniel V, et al. Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients. Transplantation. 2006; 81:1227–33

    Article  PubMed  CAS  Google Scholar 

  10. Bakker NA, Van Imhoff GW, Verschuuren EA, et al. Early onset post-transplant lymphoprolif-erative disease is associated with allograft localization. Clin Transplant. 2005;19:327–34

    Article  PubMed  Google Scholar 

  11. Hestin D, Claudon M, Champigneulles J, et al. Epstein—Barr-virus-associated post-transplant B-cell lymphoma presenting as allograft artery stenosis. Nephrol Dial Transplant. 1996;11:1164–7

    Article  PubMed  CAS  Google Scholar 

  12. Kew CE II, Lopez-Ben R, Smith JK, et al. Postransplant lymphoproliferative disorder localized near the allograft in renal transplantation. Transplantation. 2000;69:809–14

    Article  PubMed  Google Scholar 

  13. Caillard S, Pencreach S, Braun L, et al. Simultaneous development of lymphoma in recipients of renal transplants from a single donor: donor origin confirmed by human leukocytes antigen staining and microsatellite analysis. Transplantation. 2005;79:79–84

    Article  PubMed  Google Scholar 

  14. Petit B, Le Meur Y, Jaccard A, et al. Influence of host-recipient origin on clinical aspects of posttransplantation lymphoproliferative disorders in kidney transplantation. Transplantation. 2002;73:265–71

    Article  PubMed  Google Scholar 

  15. Cosio FG, Nuovo M, Delgado L, et al. EBV kidney allograft infection: possible relationship with a peri-graft localization of PTLD. Am J Transplant. 2004;4:116–23

    Article  PubMed  Google Scholar 

  16. Vaysberg M, Balatoni CE, Nepomuceno RR, et al. Rapamycin inhibits proliferation of Epstein– Barr virus-positive B-cell lymphomas through modulation of cell-cycle protein expression. Transplantation. 2007;83:1114–21

    Article  PubMed  CAS  Google Scholar 

  17. Majewski M, Korecka M, Joergensen J, et al. Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses. Transplantation. 2003;75:1710–7

    Article  PubMed  CAS  Google Scholar 

  18. El-Salem M, Raghunath PN, Marzec M, et al. Constitutive activation of mTOR signaling pathway in post-transplant lymphoproliferative disorders. Lab Invest. 2007;87:29–39

    Article  PubMed  CAS  Google Scholar 

  19. Zaltzman JS, Prasad R, Chun K, et al. Resolution of renal allograft-associated post-transplant lymphoproliferative disorder with the introduction of sirolimus. Nephrol Dial Transplant. 2005;20:1748–51

    Article  PubMed  Google Scholar 

  20. Cullis B, D'Souza R, McCullagh P, et al. Sirolimus-induced remission of posttransplantation lymphoproliferative disorder. Am J Kidney Dis. 2006;47:e67–72

    Article  PubMed  Google Scholar 

  21. Pascual J. Post-transplant lymphoproliferative disorder–the potential of proliferation signal inhibitors. Nephrol Dial Transplant. 2007;22(Suppl 1):i27–35

    Article  PubMed  CAS  Google Scholar 

  22. Kirk AD, Cherikh WS, Ring M, et al. Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab. Am J Transplant. 2007;7:2619–25

    Article  PubMed  CAS  Google Scholar 

  23. Funch DP, Walker AM, Schneider G, et al. Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients. Am J Transplant. 2005;5:2894–900

    Article  PubMed  CAS  Google Scholar 

  24. Choquet S, Leblond V, Herbrecht R, et al. Efficacy and safety of rituximab in B-cell posttransplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. Blood. 2006;107:3053–7

    Article  PubMed  CAS  Google Scholar 

  25. Choquet S, Oertel S, Leblond V, et al. Rituximab in the management of post-transplantation lym-phoproliferative disorder after solid organ transplantation: proceed with caution. Ann Hematol. 2007;86:599–607

    Article  PubMed  CAS  Google Scholar 

  26. Gross TG, Hinrichs SH, Winner J, et al. Treatment of post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation with low-dose chemotherapy. Ann Oncol. 1998;9:339–40

    Article  PubMed  CAS  Google Scholar 

  27. Fohrer C, Caillard S, Koumarianou A, et al. Long-term survival in post-transplant lymphopro-liferative disorders with a dose-adjusted ACVBP regimen. Br J Haematol. 2006;134:602–12

    Article  PubMed  CAS  Google Scholar 

  28. Choquet S, Trappe R, Leblond V, et al. CHOP-21 for the treatment of post-transplant lymphop-roliferative disorders (PTLD) following solid organ transplantation. Haematologica. 2007;92:273–4

    Article  PubMed  Google Scholar 

  29. Trofe J, Buell JF, Beebe TM, et al. Analysis of factors that influence survival in post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn Transplant Tumor Registry experience. Am J Transplant. 2005;5:775–80

    Article  PubMed  Google Scholar 

  30. Birkeland SA, Hamilton-Dutoit S, Bendtzen K. Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphop-roliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation. Transplantation. 2003;76:153–8

    Article  PubMed  CAS  Google Scholar 

  31. Karras A, Thervet E, Meur YL, et al. Successful renal retransplantation after post-transplant lymphoproliferative disease. Am J Transplant. 2004;4:1904–9

    Article  PubMed  Google Scholar 

  32. Johnson SR, Cherikh WS, Kauffman HM, et al. Retransplantation after post-transplant lymphop-roliferative disorders: an OPTN/UNOS database analysis. Am J Transplant. 2006;6:2743–9

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nephrology-Transplantation Department, Hopitaux Universitaires de Strasbourg, 1 place de l'Hopital, Strasbourg, 67091, France

    Sophie Caillard

Authors
  1. Sophie Caillard
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pediatric Kidney Transplantation, Shands Hospital at UF, University of Florida College of Medicine Medical Director, Gainesville, Florida, USA

    Vikas R. Dharnidharka (Associate Professor and Chief Fellowship Program Director Division of Pediatric Nephrology) (Associate Professor and Chief Fellowship Program Director Division of Pediatric Nephrology)

  2. Division of Infectious Diseases Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

    Michael Green (Professor of Pediatrics and Surgery) (Professor of Pediatrics and Surgery)

  3. Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

    Steven A. Webber (Professor of Pediatrics, Chief, Division of Cardiology Co-Director, Heart Center Medical Director, Pediatric Heart and Heart-Lung Transplantation) (Professor of Pediatrics, Chief, Division of Cardiology Co-Director, Heart Center Medical Director, Pediatric Heart and Heart-Lung Transplantation)

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Caillard, S. (2010). Organ Specific Issues of PTLD — Kidney. In: Dharnidharka, V.R., Green, M., Webber, S.A. (eds) Post-Transplant Lymphoproliferative Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-01653-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-01653-0_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-01652-3

  • Online ISBN: 978-3-642-01653-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation